[Federal Register Volume 63, Number 19 (Thursday, January 29, 1998)]
[Notices]
[Pages 4460-4461]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-2171]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting of the National 
Cancer Advisory Board and Its Subcommittees

    Pursuant to the Federal Advisory Committee Act, as amended, notice 
is hereby given of the meeting of the National Cancer Advisory Board 
(Board), National Cancer Institute (NCI), and its Subcommittees on 
February 2-4, 1998. The meetings of the Board and its Subcommittees 
will be open to the public as indicated below. Attendance by the public 
will be limited to space available.
    A portion of the Board meeting will be closed to the public in 
accordance with the provisions set forth in sections

[[Page 4461]]

552b (c)(4) and 552b(c)(6), Title 5 U.S.C. and section 10(d) of Public 
Law 92-463, for the review, discussion and evaluation of individual 
grant applications and for discussion of issues pertaining to 
programmatic areas and/or NCI personnel. These applications and 
discussions could reveal confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning the individuals associated with the applications or 
programs, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    The Committee Management Office, National Cancer Institute, 
National Institutes of Health, Executive Plaza North, Room 609, 6130 
Executive Boulevard, MSC 7410, Bethesda, Maryland 20892-7410, (301) 
496-5708 will provide summaries of the meetings and rosters of the 
Board members, upon request.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Mrs. Linda Quick-Cameron, Committee Management Officer, at 
(301) 496-5708 in advance of the meeting.

    Name of Committee: Subcommittee on Cancer Centers.
    Contact Person: Dr. Brian Kimes, Executive Secretary, National 
Cancer Institute, NIH, Executive Plaza North, Room 502, 6130 
Executive Blvd., Bethesda, MD 20892, (301) 496-8537.
    Date of Meeting: February 2, 1998.
    Place of Meeting: Hyatt Regency Bethesda, One Bethesda Metro, 
Bethesda, MD 20814.
    Open: 7:00 p.m. to 8:00 p.m.
    Agenda: To Discuss Policies and Procedures of Cancer Programs.

    Name of Committee: Subcommittee on Planning and Budget.
    Contact Person: Ms. Cherie Nichols, Executive Secretary, 
National Cancer Institute, NIH, 7550 Wisconsin Avenue, Room 312, MSC 
9010, Bethesda, MD 20892-9010, (301) 496-5515.
    Date of Meeting: February 3, 1998.
    Place of Meeting: Natcher Building, Atlanta Room, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Agenda: To Discuss the NCI Budget and Various Planning Issues.

    Name of Committee: Subcommittee on Clinical Investigations.
    Contact Person: Dr. Philip Shein, Executive Secretary, National 
Cancer Institute, NIH, Building 31, Room 3A44, MSC 2440, 9000 
Rockville Pike, (301) 496-4291.
    Date of Meeting: February 3, 1998.
    Place of Meeting: Natcher Building, Conference Room F, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: Approximately 5:15 p.m. to Adjournment.
    Agenda: To Discuss the Design of Prospective Studies of the 
Impact of Managed Care on Cancer Clinical Investigations, Education 
and Training.

    Name of Committee: National Cancer Advisory Board.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600, 
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
5147.
    Dates of Meeting: February 3-4, 1998.
    Place of Meeting: Natcher Building, Conference Room E1 & E2, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 
20892.
    Open: February 3--9:00 a.m. to 4:00 p.m.; February 4--9:00 a.m. 
to 11:45 a.m.
    Agenda: Report of the Deputy Director, National Cancer 
Institute; Legislative Update; Report of the President's Cancer 
Panel; Remarks by the President, American Association for Cancer 
Research; Updates, Bishop/Calabresi: Closure; NCI Office of Special 
Populations Research; Status Report: Director, Center for Scientific 
Review; Mini Symposium; Evidence/Based Medicine & The Cocharan 
Collaboration; Implementation of Program Review Group 
Recommendations; Director's Consumer Liaison Group; Subcommittee 
Reports; Annual Delegations of Authority; Extramural Reports and 
Other NCAB Business.
    Closed: February 3--4:15 p.m. to Approximately 5:15 p.m.
    Agenda: Review and Discussion of Grant Applications and 
Extramural/Intramural, Programmatic and Personnel Policies.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

(Catalog of Federal Domestic Assistance Program Numbers (93.393, 
Cancer Cause and Prevention Research: 93.392, Cancer Detection and 
Diagnosis Research; 93.394, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: January 23, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-2171 Filed 1-28-98; 8:45 am]
BILLING CODE 4140-01-M